EMINENCE ENT (00616) completed the issuance of 20 million shares for sale, raising approximately HK$5.94 million.

EMINENCE ENT(00616) announces that all conditions set out in the placement agreement have been met, and the completion of the placement was executed on December 17, 2025 in accordance with the terms and conditions of the placement agreement. Under the placement agreement, the company has issued and allotted 20 million placement shares to Mr. Cheung Hong, an underwriter independent of the company, Wing Yick, and their respective associates, at a placement price of HK$0.30 per share, representing approximately 1.19% of the company's issued share capital (after the issuance and allotment of the placement shares). The total proceeds from the placement amount to HK$6 million, and the net proceeds from the placement (after deduction of placement commission and other related costs and expenses) is approximately HK$5.94 million. The company intends to utilize the estimated net proceeds from the placement for general working capital of the group over the next one to two months, as follows: approximately 6% of the net proceeds will be used for professional fees; approximately 35% of the net proceeds will be used for staff salaries; and approximately 59% of the net proceeds will be used for utility expenses and other expenses.